Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in glenmark pharmaceuticals

Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg

Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg

Read More

Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure

Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure

Read More

Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg

Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg

Read More

Glenmark announces Q2 FY20-21 results

Glenmark announces Q2 FY20-21 results

Read More

Glenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5 mg, 1 mg and 2 mg

Glenmark Pharmaceuticals receives ANDA approval for Sirolimus tablets, 0.5 mg, 1 mg and 2 mg

Read More

Glenmark introduces NINDANIB (Nintedanib) and is amongst the first to launch the branded generic version at an affordable cost for the treatment of Pulmonary Fibrosis in India

Glenmark introduces NINDANIB (Nintedanib) and is amongst the first to launch the branded generic version at an affordable cost for the treatment of Pulmonary Fibrosis in India

Read More

Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg

Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg

Read More

Glenmark appoints Dipankar Bhattacharjee to its Board of Directors

Glenmark appoints Dipankar Bhattacharjee to its Board of Directors

Read More

Glenmark Introduces Higher Strength Of Fabiflu To Reduce Pill Burden Of Covid-19 Treatment

The higher strength will improve patient compliance and experience by effectively reducing the number of tablets that patients require per day

Read More

Glenmark Cuts COVID-19 Drug Favipiravir Price By 27 %

"Our priority from the start of this pandemic has been to offer patients in India an effective treatment for COVID-19 while also ensuring accessibility to the masses,"

Read More

Fitch affirms Glenmark Pharmaceuticals at BB, withdraws proposed bond rating

Fitch affirms Glenmark Pharmaceuticals at BB, withdraws proposed bond rating

Read More

Hindustan Unilever Completes Acquisition Of VWash From Glenmark Pharma

HUL has acquired intellectual property rights including trademarks, design and know-how related to the VWash brand worldwide.

Read More

Sensex Closes 180 Points Up, Glenmark Pharma Jumps 27 Pc

Cipla's stock jumped by 2.9 per cent to Rs 655.80 per unit after it announced the launch of remdesivir under its brand name Cipremi.

Read More

Glenmark, Cipla Stocks Surge After Nod To Launch Drugs For Mild-to-moderate COVID-19 Infections

At the same time, Cipla's stock jumped by 4.3 per cent to Rs 664.45 per unit after it announced the launch of remdesivir under its brand name Cipremi.

Read More

Glenmark Pharmaceuticals Gets USFDA Nod For Fingolimod Capsules

Shares of Glenmark Pharmaceuticals were trading at Rs 411.20 a piece on BSE in morning trade, up 1.44 per cent from their previous close.

Read More